Skip to main content

Table 4 Cost-minimization analyses

From: Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan

Regimen

Comparison of cost

Comparison of effectiveness

Cost-minimization analyses

CapeOX vs. mFOLFOX6

Comparable

Comparable

Comparable

UFT/LV vs. S-1

Higher in UFT/LV than S-1

Comparable

S-1 superior to UFT/LV

UFT/LV vs. capecitabine

Higher in UFT/LV than capecitabine

Comparable

Capecitabine superior to UFT/LV